Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$1.84 USD
-0.05 (-2.78%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.81 -0.03 (-1.63%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Minerva Neurosciences, Inc's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NERV 1.84 -0.05(-2.78%)
Will NERV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NERV based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NERV
Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
NERV's Cash Reserves Decrease by $4.1 Million in Q1 2025 | NERV Stock News
Minerva Neurosciences GAAP EPS of -$0.50
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates | NERV ...
Minerva reports Q1 EPS (50c) vs ($1.13) last year